Verano Holdings (VRNO) Treasury Shares (2021 - 2026)
Verano Holdings (VRNO) posted quarterly Treasury Shares of $2.6 million for Q1 2026, down 58.03% year-over-year from $6.2 million in Q1 2025, and down 7.87% quarter-over-quarter from $2.8 million in Q4 2025.
Verano Holdings (VRNO) Treasury Shares (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has reported Treasury Shares for 6 consecutive years, with $2.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Treasury Shares fell 58.03% year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at $2.6 million (down 58.03% YoY), while the FY2025 annual figure was $2.8 million, down 55.46% from the prior year.
- Treasury Shares retreated to $2.6 million in Q1 2026 per VRNO's latest filing, from $2.8 million in the prior quarter.
- Across five years, Treasury Shares topped out at $9.9 million in Q2 2023 and bottomed at $2.6 million in Q1 2026.
- Historically, Treasury Shares has averaged $5.9 million across 5 years, with a median of $5.7 million in 2025.
- Annual changes were most pronounced in 2023 — Treasury Shares surged 227.99% — and 2026, when it slumped 58.03%.
- Verano Holdings' Treasury Shares stood at $3.0 million in 2022, then soared by 195.59% to $8.8 million in 2023, then slipped by 28.48% to $6.3 million in 2024, then sank by 55.46% to $2.8 million in 2025, then decreased by 7.87% to $2.6 million in 2026.
- Business Quant data shows VRNO's Treasury Shares at $2.6 million in Q1 2026, $2.8 million in Q4 2025, and $4.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 4.13 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.30 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -297.63 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 35.35 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 19.00 Mn |
| 10 | Verano Holdings | 433.71 Mn | 348.51 Mn | 99.70 Mn | 2.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.18 Mn |
| Jun 30, 2026 | 1.18 Mn |
| Jun 30, 2026 | 2.00 Mn |
| Jun 30, 2026 | 2.00 Mn |
| Mar 31, 2026 | 2.59 Mn |
| Mar 31, 2026 | 2.59 Mn |
| Dec 31, 2025 | 2.81 Mn |
| Dec 31, 2025 | 2.81 Mn |
| Sep 30, 2025 | 4.79 Mn |
| Sep 30, 2025 | 4.79 Mn |
| Jun 30, 2025 | 5.34 Mn |
| Jun 30, 2025 | 5.34 Mn |
| Mar 31, 2025 | 6.16 Mn |
| Mar 31, 2025 | 6.16 Mn |
| Dec 31, 2024 | 6.30 Mn |
| Dec 31, 2024 | 6.30 Mn |
| Sep 30, 2024 | 8.61 Mn |
| Sep 30, 2024 | 8.61 Mn |
| Jun 30, 2024 | 8.66 Mn |
| Jun 30, 2024 | 8.66 Mn |